Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CAWELLO, W")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 18 of 18

  • Page / 1
Export

Selection :

  • and

PHARMAKODYNAMIK UND PHARMAKOKINETIK VON BEMETIZID IM VERGLEICH ZUR HYDROCHLOROTHIAZID. EINE KONTROLLIERTE HUMANPHARMAKOLOGISCHE STUDIE DER AKUTWIRKUNGEN = PHARMACODYNAMIE ET PHARMACOCINETIQUE DU BEMETIZIDE PAR COMPARAISON AVEC L'HYDROCHLOROTHIAZIDE. ETUDE PHARMACOLOGIQUE HUMAINE CONTROLEE DES ACTIONS AIGUESPIPER C; CAWELLO W; BONN R et al.1983; ARZNEIMITTEL-FORSCHUNG; ISSN 0004-4172; DEU; DA. 1983; VOL. 33; NO 7; PP. 988-996; ABS. ENG; BIBL. 23 REF.Article

Kinetic studies of the tissue binding tendency of the new vasodilator pildralazineNOACK, E; CAWELLO, W; BONN, R et al.Arzneimittel-Forschung. 1987, Vol 37, Num 4, pp 407-409, issn 0004-4172Article

Moexipril shows a long duration of action related to an extended pharmacokinetic half-life and prolonged ACE inhibitionCAWELLO, W; BOEKENS, H; WAITZINGER, J et al.International journal of clinical pharmacology and therapeutics. 2002, Vol 40, Num 1, pp 9-17, issn 0946-1965Article

The saluretic effect of the thiazide diuretic bemetizide in relation to the glomerular filtration rateKNAUF, H; CAWELLO, W; SCHMIDT, G et al.European journal of clinical pharmacology. 1994, Vol 46, Num 1, pp 9-13, issn 0031-6970Article

Isosorbide-5-nitrate sustained-release pellets. An example of computer-supported drug developmentZERBE, H; LUCKOW, V; CAWELLO, W et al.Pharmaceutical research. 1985, Num 1, pp 30-36, issn 0724-8741Article

Gas chromatography/negative ion chemical ionization triple quadrupole mass spectrometric determination and pharmacokinetics of 11α-hydroxy-9,15-dioxo-2,3,4,5,20-pentanor-19-carboxyprostanoic acid in plasmaSCHWEER, H; CAWELLO, W; SEYBERTH, H. W et al.Prostaglandins, leukotrienes and essential fatty acids. 1994, Vol 51, Num 6, pp 401-405, issn 0952-3278Article

The correlation between pharmacodynamics and pharmacokinetics : Basics of pharmacokinetics-pharmacodynamics modelingCAWELLO, W; ANTONUCCI, T.Journal of clinical pharmacology. 1997, Vol 37, Num 1, pp 65S-69S, issn 0091-2700, SUPConference Paper

Lack of a pharmacokinetic interaction between moexipril and hydrochlorothiazideHUTT, V; MICHAELIS, K; VERBESSELT, R et al.European journal of clinical pharmacology. 1996, Vol 51, Num 3-4, pp 339-344, issn 0031-6970Article

Dose proportional pharmacokinetics of alprostadil (prostaglandin E1) in healthy volunteers following intravenous infusionCAWELLO, W; LEONHARDT, A; SCHWEER, H et al.British journal of clinical pharmacology. 1995, Vol 40, Num 3, pp 273-276, issn 0306-5251Article

Metabolism and pharmacokinetics of prostaglandin E1 administered by intravenous infusion in human subjectsCAWELLO, W; SCHWEER, H; MÜLLER, R et al.European journal of clinical pharmacology. 1994, Vol 46, Num 3, pp 275-277, issn 0031-6970Article

Thorough QT/QTc Study in Patients With Advanced Parkinson's Disease : Cardiac Safety of RotigotineMALIK, M; ANDREAS, J.-O; HNATKOVA, K et al.Clinical pharmacology and therapeutics. 2008, Vol 84, Num 5, pp 595-603, issn 0009-9236, 9 p.Article

Pharmakokinetik von prostaglandin E1 bei infusion während einer Hämodialyse = Pharmacokinetics of prostaglandin E1 in patients undergoing haemodialysisCAWELLO, W; SAMADI, N; SCHWEER, H et al.Vasa. Supplementum. 1999, Vol 54, pp 17-19, issn 0251-1029Conference Paper

Connection of pharmacokinetics and pharmacodynamics - how does it work?CAWELLO, W.International journal of clinical pharmacology and therapeutics. 1997, Vol 35, Num 10, pp 414-417, issn 0946-1965Conference Paper

Pharmacokinetics of prostaglandin E1 and its main metabolites after intracavernous injection and short-term infusion of prostaglandin E1 in patients with erectile dysfunctionCAWELLO, W; SCHWEER, H; DIETRICH, B et al.The Journal of urology. 1997, Vol 158, Num 4, pp 1403-1407, issn 0022-5347Article

Moexipril does not alter the pharmacokinetics or pharmacodynamics of warfarinVAN HECKEN, A; VERBESSELT, R; DEPRE, M et al.European journal of clinical pharmacology. 1993, Vol 45, Num 3, pp 291-293, issn 0031-6970Article

Investigation of the gastrointestinal transit and in vivo drug release of isosorbide-5-nitrate pelletsFISCHER, W; BOERTZ, A; DAVIS, S. S et al.Pharmaceutical research. 1987, Vol 4, Num 6, pp 480-485, issn 0724-8741Article

Pharmacokinetics of isosorbide-5-nitrate during haemodialysis and peritoneal dialysisEVERS, J; BONN, R; BOERTZ, A et al.European journal of clinical pharmacology. 1987, Vol 32, Num 5, pp 503-505, issn 0031-6970Article

Pharmacokinetics of isosorbide-5-nitrate in renal failureEVERS, J; KRAKAMP, B; KLIMKAIT, W et al.European journal of clinical pharmacology. 1986, Vol 30, Num 3, pp 349-350, issn 0031-6970Article

  • Page / 1